The Europe Nephrology and Urology Devices Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 24,888.2 thousand units, showcasing a growth of 5.7% (2019-2022).
Nephrology and urology devices refer to the equipment and tools designed for diagnosing, treating, and managing kidney and urinary tract diseases. These devices are instrumental in enhancing patient outcomes, improving quality of life, and addressing the complex nature of nephrological and urological disorders. The market encompasses diagnostic and therapeutic devices, reflecting the comprehensive approach required to manage these intricate medical conditions. The expansion of the nephrology and urology devices market is driven by a rise in chronic kidney disease (CKD) and end-stage renal disease (ESRD). Thus, the rising prevalence of chronic kidney disease and other urological conditions has propelled the demand for devices, driving growth during the market forecast for nephrology and urology devices.
Urological and nephrological disorders can be managed noninvasively through the use of alternative medications, laser therapy, and ultrasound imaging. Implementing these practicable alternatives offers patients alternatives to dialysis machines, endoscopes, and urinary catheters, which are utilized in treating these conditions. As a result, the market for nephrology and urology devices is stimulated. The Supply chains of most healthcare organizations are anticipated to function seamlessly and effectively throughout the forecast period due to the progressive easing of lockdown restrictions. Consequently, the market is expected to undergo significant expansion in the years to come.
The aging demographic in many European countries significantly influences the expansion of the nephrology and urology devices market. Older individuals are more susceptible to kidney-related conditions and urological disorders, increasing the demand for related medical devices. Therefore, the factors mentioned above will propel the market growth in this region.
The Germany market dominated the Europe Nephrology and Urology Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $531.8 million by 2030. The UK market is exhibiting a CAGR of 5.1% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.9% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Based on Application, the market is segmented into Kidney Diseases, Bladder Disorders, Urolithiasis, Urological Cancer & BPH, and Others. Based on Product, the market is segmented into Urology Guidewires, Stone Basket, Renal Dilators, Mesh & Inserts, Ureteral Catheters, Urinary Stents, PCN Catheters, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Nephrology And Urology Devices Market will Hit $8.5 Billion by 2030, at a CAGR of 6.3%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
By End-use (Volume, Thousand Units, USD Billion, 2019-2030)
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
